Healthcare -
Biotechnology - NASDAQ - US
$ 4.14
-2.62 %
$ 178 M
Market Cap
-6.39
P/E
DMAC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DMAC - DiaMedica Therapeutics Inc.
12 M
LAST VALUE
4373.25%
2 YEAR CAGR
179.75%
5 YEAR CAGR
21.73%
10 YEAR CAGR